A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique

This is a single-center, open-label, Phase Ib/II study aiming to assess the perioperative safety and postoperative outcomes of a novel surgical technique in treating primary adenocarcinoma located in the upper 1/3 of the stomach or gastroesophageal junction (Siewert II or III). The study will enroll 30 patients who will undergo totally laparoscopic proximal gastrectomy with esophagogastrostomy by fissure technique. Clinical data will be collected to evaluate perioperative safety. Patients will be followed for at least 3 months, during which endoscopy will be performed to analyze occurrences a

Trial Details

NCT ID
NCT06300879
Phase
NA
Sponsor
Huashan Hospital
Status
RECRUITING
Cancer Type
Gastric Cancer
Interventions
  • Performing totally laparoscopic proximal gastrectomy with esophagogastrostomy by fissure technique
Locations (sample)
  • Shanghai, Shanghai Municipality, China|31.22222,121.45806

Key Eligibility Criteria

  • Age between 18 and 75 years old;
  • Pathologically confirmed as adenocarcinoma;
  • Primary tumor located in the upper 1/3 of the stomach or the gastroesophageal junction (Siewert II or III);
  • If it is adenocarcinoma of the upper 1/3 of the stomach, cT1N0M0 should be met.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Gastric Cancer Trials on Trialify →